Identify your next opportunity and capitalise on value-generating growth.
Identify & value your investments and mitigate risks to create shareholder value.
A department store wanted to explore the commercial feasibility of expanding into new countries, and understand the likely returns.
Asset screening and prioritization for strategic in-licensing opportunities in oncology.
The client was preparing to launch a novel 5-HT3 anti-emetic into the chemotherapy-induced nausea and vomiting (CINV) market in the US, EU5 and Japan, and needed to know the size of the available patient population and the likelihood of use of its new product.
Our consultants work closely with you to understand requirements and develop a tailored approach and deliverables.
